CME
48
2
PDCO
46
3
AMGN
39
6
ORLY
65
4
DTE
67
2
MAR
68
3
WBA
67
4
AEP
51
6
WEC
51
6
CI
66
7
KHC
47
2
PPL
60
3
HRL
30
3
UAL
77
4
JBHT
63
7
ECL
72
2
HSIC
47
5
LEN
61
2
CSCO
67
4
WY
50
6
CME
48
2
PDCO
46
3
AMGN
39
6
ORLY
65
4
DTE
67
2
MAR
68
3
WBA
67
4
AEP
51
6
WEC
51
6
CI
66
7
KHC
47
2
PPL
60
3
HRL
30
3
UAL
77
4
JBHT
63
7
ECL
72
2
HSIC
47
5
LEN
61
2
CSCO
67
4
WY
50
6
Financhill
Back

Grand Canyon Education Vs. Kymera Therapeutics Industry Stock Comparison

Sell
36

LOPE
Grand Canyon Education

Last Price:
133.33
Seasonality Move:
6.62%
Buy
71

KYMR
Kymera Therapeutics

Last Price:
46.27
Seasonality Move:
65.72%
Sell
36
Grand Canyon Education (LOPE) is a Sell

Is Grand Canyon Education a Buy, Sell or Hold?

  • The current Grand Canyon Education [LOPE] share price is $133.46. The Score for LOPE is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • LOPE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
71
Kymera Therapeutics (KYMR) is a Buy

Is Kymera Therapeutics a Buy, Sell or Hold?

  • The current Kymera Therapeutics [KYMR] share price is $49.02. The Score for KYMR is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

LOPE Stock Price Chart

What is Grand Canyon Education's stock price today?

  • The Grand Canyon Education share price today is $133.46
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LOPE is experiencing slight selling pressure.

KYMR Stock Price Chart

What is Kymera Therapeutics's stock price today?

  • The Kymera Therapeutics share price today is $49.02
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing buying pressure, which is a positive indicator for future bullish movement.

LOPE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.43 Sell
Relative Strength Index (14 RSI): 35.35 Sell
Chaikin Money Flow: -76278 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (135.48 - 143.58) Sell
Bollinger Bands (100): (137.1 - 147.5) Sell

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.28 Sell
Relative Strength Index (14 RSI): 59.12 Buy
Chaikin Money Flow: 317205 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (43.81 - 49.49) Buy
Bollinger Bands (100): (34.86 - 47.92) Buy

LOPE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 134.1 Sell
20-day SMA: 138.84 Sell
50-day SMA: 140.54 Sell
200-day SMA: 137.6 Sell
8-day EMA: 134.74 Sell
20-day EMA: 137.39 Sell
50-day EMA: 140.08 Sell
200-day EMA: 137.05 Sell

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 44.58 Buy
20-day SMA: 46.67 Buy
50-day SMA: 46.11 Buy
200-day SMA: 38.62 Buy
8-day EMA: 45.67 Buy
20-day EMA: 45.85 Buy
50-day EMA: 45.2 Buy
200-day EMA: 38.5 Buy

Grand Canyon Education Earnings Growth & LOPE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.01 per share, and an increase next year of $0.79 per share.

Kymera Therapeutics Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and a decrease next year of $0.47 per share.

Grand Canyon Education Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):